| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |